|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 08855697.2 (espacenet) (Federated) (European Patent Register), 20081126 | | Patent/reg. no. and date | DK/EP 2225377, 20140108 | | Publication date | 20100908 | | Priority no. and date | US 990125 P, 20071126 | | EP pub. no. and date |
EP 2225377 20100908 | | Effective date | | | Applicant/owner | Santaris Pharma A/S, Fremtidsvej 3, 2970 Hørsholm, DK | | Applicant ref. no. | P037343EP | | Inventor | WORM, Jesper, Viktoriagade 28 2 tv., 1655 København V, DK | | Representative | | | Opponent | | | IPC Class | C12N 15/113 (2010.01) | | Title | LNA-ANTAGONISTER, DER ER MÅLRETTET MOD ANDROGENRECEPTOREN | | Int. application no. | DK2008000417 | | Int. publication no. | WO2009068033 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
